Lee Kramm is a Board-certified ophthalmologist and regulatory professional who served as a medical officer and senior reviewer at the Division of Ophthalmic, Neurological and ENT Devices (DONED) at FDA. Since 2012, first under ClinReg Consulting Services and now with Regulatory Pathways, he provides client services as a senior clinical and regulatory consultant for devices, biologics, and drug products. Dr. Kramm has reviewed and prepared clinical trial plans, classification opinion memos, de novo applications, pre-submissions, IDEs, INDs, PMAs, 510(k)s, HUD’s, NDAs, Breakthrough Designations, and requests for designation. Services also include standing as official correspondent for communications between clients and regulatory bodies. He earned his Master of Science in Biomedical Engineering from the Tulane University School of Science and Engineering and his medical degree from the University of Miami School of Medicine.
Regulatory Pathways Group Inc.
a California corporation
Inquiries and general information:
info@regulatorypathways.com